Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05819021 · ClinicalTrials.gov registry record
Open Label Optimization Study
A clinical trial of Major Depressive Disorder, sponsored by Magnus Medical.
- Active
- Registry status
- 1,000
- Enrollment target
- 7
- Study locations
NCT05819021 is a study of Major Depressive Disorder that is active but no longer recruiting, run by Magnus Medical. The registered enrollment target is 1,000 participants, above the 373-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (168% higher). The trial reports 7 study locations across 4 states.
The verdict
NCT05819021, a study of Major Depressive Disorder, is active but no longer recruiting, sponsored by Magnus Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this observational study is to demonstrate effectiveness in the treatment of Major Depressive Disorder The primary objective is to assess the effectiveness in the treatment of Major Depressive Disorder using the CGI-I at the end of the treatment Participants will receive 10 treatments per day for 5 days (M-F) of SAINT®
Conditions Studied
Interventions
- DEVICE SAINT® Neuromodulation System (NMS)
Study Locations (7)
California
- BrainHealth Solutions - Costa Mesa
- LA TMS - Los Angeles
- Integral TMS - Sunnyvale
- Acacia Research Center - Sunnyvale
Massachusetts
- Boston Precision Neurotherapeutics - Natick
New York
- Fermata - Brooklyn
Washington
- Seattle Neuropsychiatric Treatment Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2027-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05819021
The ClinicalTrials.gov registry entry for NCT05819021 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 373-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (168% higher). The listed sponsor is Magnus Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which SAINT® Neuromodulation System (NMS) is the first listed.
NCT05819021 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT05819021 about?
NCT05819021 is a clinical study titled "Open Label Optimization Study". The goal of this observational study is to demonstrate effectiveness in the treatment of Major Depressive Disorder The primary objective is to assess the effectiveness in the treatment of Major Depressive Disorder using the CGI-I at the end of the treatment Participants will receive 10 treatments ...
What is the current status of trial NCT05819021?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2023-04-06. Estimated completion is 2027-04-15.
What conditions does trial NCT05819021 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT05819021?
The interventions under investigation include: SAINT® Neuromodulation System (NMS) (DEVICE).
Who is sponsoring clinical trial NCT05819021?
This trial is sponsored by Magnus Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05819021 being conducted?
This trial has 7 study locations across California, Massachusetts, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.